Advertisement

Topics

Celgene, Agios get FDA OK for leukaemia drug Idhifa

06:24 EDT 3 Aug 2017 | PMLIVE

Duo’s drug becomes first new AML therapy since Novartis' Rydapt

Original Article: Celgene, Agios get FDA OK for leukaemia drug Idhifa

NEXT ARTICLE

More From BioPortfolio on "Celgene, Agios get FDA OK for leukaemia drug Idhifa"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...